Trademark: 87978555
Status Date
Tuesday, November 6, 2018
Registration Number
5603397
Registration Date
Tuesday, November 6, 2018
Filing Date
Tuesday, June 20, 2017
Published for Opposition
Tuesday, January 2, 2018
5 Biological drugs for use in treating cancer, and autoimmunity; therapeutic and medical diagnostic agents and preparations for use in therapies and diagnosis for cancer, and autoimmunity; biochemicals, immunoglobulins and antigen-binding fragments for use in therapies and medical diagnosis for cancer, and autoimmunity; therapeutic and diagnostic agents, preparations and substances for medical purposes for targeting application to immune system, cells, or genes; immune modulators, immunoglobulin drug conjugates, immunotherapies and therapeutic and diagnostic agents, preparations and substances in the field of dysregulated proteolytic activity for medical purposes; immunotherapies and therapeutic and medical diagnostic agents, preparations and substances in the field of cancer, and autoimmunity for medical purposes
The mark consists of three semi-circles aligned next to each other. The first semi-circle has its vertical opening facing to the right. It is separated by a narrow white space from the second semi-circle, whose vertical opening faces to the left. The third semi-circle's vertical opening faces to the right. The tips of the circular apexes of the second and third semi circles are adjoined to each other.
Color is not claimed as a feature of the mark.
Nov 6, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jan 30, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 30, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 21, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 21, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 16, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 16, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 6, 2018
Registered-Principal Register
Oct 2, 2018
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 1, 2018
Allowed Principal Register - Sou Accepted
Sep 18, 2018
Notice Of Design Search Code E-Mailed
Sep 18, 2018
Notice Of Approval Of Extension Request E-Mailed
Sep 17, 2018
Statement Of Use Processing Complete
Aug 21, 2018
Use Amendment Filed
Aug 20, 2018
Sou Extension 1 Granted
Aug 20, 2018
Sou Extension 1 Filed
Sep 17, 2018
Divisional Processing Complete
Aug 21, 2018
Divisional Request Received
Sep 17, 2018
Case Assigned To Intent To Use Paralegal
Aug 21, 2018
Teas Request To Divide Received
Aug 21, 2018
Teas Statement Of Use Received
Aug 20, 2018
Sou Teas Extension Received
Feb 27, 2018
Noa E-Mailed - Sou Required From Applicant
Feb 20, 2018
Changes/Corrections After Pub Approval Entered
Feb 16, 2018
Assigned To Petition Staff
Feb 6, 2018
Teas Post Publication Amendment Received
Jan 2, 2018
Official Gazette Publication Confirmation E-Mailed
Jan 2, 2018
Published For Opposition
Dec 13, 2017
Notification Of Notice Of Publication E-Mailed
Nov 26, 2017
Assigned To Lie
Nov 14, 2017
Approved For Pub - Principal Register
Nov 14, 2017
Examiner's Amendment Entered
Nov 14, 2017
Notification Of Examiners Amendment E-Mailed
Nov 14, 2017
Examiners Amendment E-Mailed
Nov 14, 2017
Examiners Amendment -Written
Nov 10, 2017
Previous Allowance Count Withdrawn
Nov 10, 2017
Approved For Pub - Principal Register
Nov 9, 2017
Teas/Email Correspondence Entered
Nov 8, 2017
Correspondence Received In Law Office
Nov 8, 2017
Teas Response To Office Action Received
Jul 24, 2017
Notification Of Examiner's Amendment/Priority Action E-Mailed
Jul 24, 2017
Examiner's Amendment/Priority Action E-Mailed
Jul 24, 2017
Combined Examiner's Amendment/Priority Action Automatic Entry
Jul 24, 2017
Examiners Amendment And/Or Priority Action - Completed
Jul 17, 2017
Assigned To Examiner
Jun 28, 2017
Notice Of Design Search Code E-Mailed
Jun 27, 2017
New Application Office Supplied Data Entered
Jun 23, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
